Literature DB >> 26857185

Incidence of real-time recordings of pulmonary vein potentials using the third-generation short-tip cryoballoon.

Gian-Battista Chierchia1, Giacomo Mugnai2, Erwin Ströker2, Vedran Velagic2, Burak Hünük2, Darragh Moran2, Ebru Hacioglu2, Jan Poelaert3, Christian Verborgh3, Vincent Umbrain3, Stefan Beckers3, Diego Ruggiero2, Pedro Brugada2, Carlo de Asmundis2.   

Abstract

AIMS: The third-generation Cryoballoon Advance Short-tip (CB-ST) has been designed with a 40% shortened tip length compared with the former second-generation CB Advance device. Ideally, a shorter tip should permit an improved visualization of real-time (RT) recordings in the pulmonary vein (PV) due to a more proximal positioning of the inner lumen mapping catheter. In the present study, we sought to analyse the rate of visualization of RT recordings in our first series of patients with the CB-ST device. METHODS AND
RESULTS: All consecutive patients having undergone CB ablation using CB-ST technology were analysed. Exclusion criteria were the presence of an intracavitary thrombus, uncontrolled heart failure, moderate or severe valvular disease, and contraindications to general anaesthesia. A total of 60 consecutive patients (60.5 ± 11.2 years, 62% males) were evaluated. Real-time recordings were detected in 209 of 240 PVs (87.1%). Specifically, RT recordings could be visualized in 55 left superior PVs (91.7%), 51 left inferior PVs (85.0%), 53 right superior PVs (88.3%), and 50 right inferior PVs (83.3).
CONCLUSION: The rate of visualization of RT recordings is significantly high during third-generation CB-ST ablation. Real-time recordings can be visualized in ∼87.1% of veins with this novel cryoballoon. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Cryoballoon; Pulmonary vein isolation; Short tip

Mesh:

Year:  2016        PMID: 26857185     DOI: 10.1093/europace/euv452

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  6 in total

1.  Earliest pulmonary vein potential-guided cryoballoon ablation for atrial fibrillation.

Authors:  Yoshiaki Mizutani; Masaaki Kanashiro; Yuichiro Makino; Akinori Satake; Wataru Suzuki; Masanari Kurobe; Kouji Mizutani; Hitoshi Ichimiya; Yasuhiro Uchida; Junji Watanabe; Satoshi Ichimiya; Yasuya Inden; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2019-07-11       Impact factor: 2.037

Review 2.  The Impact of Advances in Atrial Fibrillation Ablation Devices on the Incidence and Prevention of Complications.

Authors:  Fehmi Keçe; Katja Zeppenfeld; Serge A Trines
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

3.  Time-to-effect guided pulmonary vein isolation utilizing the third-generation versus second generation cryoballoon: One year clinical success.

Authors:  Christian-Hendrik Heeger; Christopher Schuette; Valentina Seitelberger; Erik Wissner; Andreas Rillig; Shibu Mathew; Bruno Reissmann; Christine Lemes; Tilman Maurer; Thomas Fink; Osamu Inaba; Naotaka Hashiguchi; Francesco Santoro; Feifan Ouyang; Karl-Heinz Kuck; Andreas Metzner
Journal:  Cardiol J       Date:  2018-06-20       Impact factor: 2.737

4.  Practical Techniques in Cryoballoon Ablation: How to Isolate Inferior Pulmonary Veins.

Authors:  Shaojie Chen; Boris Schmidt; Stefano Bordignon; Fabrizio Bologna; Takahiko Nagase; Laura Perrotta; K R Julian Chun
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-03

Review 5.  Cryoballoon ablation of atrial fibrillation: a practical and effective approach.

Authors:  George Georgiopoulos; Dimitris Tsiachris; Antonis S Manolis
Journal:  Clin Cardiol       Date:  2016-12-19       Impact factor: 2.882

6.  Acute safety, efficacy, and advantages of a novel cryoballoon ablation system for pulmonary vein isolation in patients with paroxysmal atrial fibrillation: initial clinical experience.

Authors:  Ante Anic; Nigel Lever; Andrew Martin; Toni Breskovic; Matthew S Sulkin; Elizabeth Duffy; Walid I Saliba; Mark J Niebauer; Oussama M Wazni; Niraj Varma
Journal:  Europace       Date:  2021-03-17       Impact factor: 5.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.